Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism BTN2A1 inhibitors(Butyrophilin subfamily 2 member A1 inhibitors), BTN2A2 inhibitors(Butyrophilin subfamily 2 member A2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ![]() |
Active Organization- |
Inactive Organization ![]() |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | FR | ![]() | - |